KLF7 and metabolic syndrome: In conclusion, our findings show that KLF7 is a unique regulator of metabolism from the infant to adult stages and serves as a molecular switch that simultaneously represses and activates genes involved in glycolysis and FAO, KLF7 may be an attractive therapeutic target for metabolic syndrome at different life cycles.